Elligo expands research network with oncology center partnership

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/LewisTsePuiLung)
(Image: Getty/LewisTsePuiLung)

Related tags: Elligo Health Research, Clinical research, Research, Clinical trial, Partnership, Breast cancer, Oncology

Elligo expands its Research Ready network and adds its first oncology practice through a partnership with Austin Cancer Center, which is currently enrolling patients for breast cancer studies.

The health research organization, Elligo, will work with the Austin Cancer Center (ACC) to add its clinical research network,while ACC’s oncologists will offer research as a care option.

Mary Costello, VP of clinic development and patient advocacy at Elligo told us, “Most research starts at academic medical centers and standalone research dedicated practices. By partnering with health care providers in the community, Elligo helps extend access and expand the reach of the study itself.”

According to ACC, the partnership enables its patients to remain under its care while receiving opportunities to participate in clinical studies through Elligo’s Research Ready network. The network operates on its Goes Direct approach connecting patients and sites to research studies across the industry.

Costello said Elligo selected to work with physicians in Austin, TX, the 11th​ largest city in the US, “to allow cancer patients the opportunity to access clinical research in their own community, which increases the likelihood they will participate and extends the chance to participate to all patients, not just those fortunate enough to be able to travel outside of their community.”

ACC currently offers clinical care across medical oncology, comprehensive breast care and breast oncology, gynecologic oncology, radiation oncology, neuro-oncology, and diagnostic and interventional radiology specialties.

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us

Products

View more

Webinars